Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Buy

A

The Bank of N.T. Butterfield & Son Limited (NTB)

https://www.butterfieldgroup.com

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, the Cayman Islands, the Channel Islands, and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. It generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/16/2016

Market Cap

1,708,757,960

Shares Outstanding

48,690,000

Weighted SO

48,070,723

Total Employees

N/A

Upcoming Earnings

07/22/2024

Similar Tickers

PJT --.--%

NBHC --.--%

FBK --.--%

NRIM --.--%

EIG --.--%

Beta

1.1890

Last Div

1.7600

Range

24.62-40.55

Chg

0.5800

Avg Vol

212369

Mkt Cap

1708757960

Exch

NYSE

Country

BM

Phone

14412951111

DCF Diff

-40.6167

DCF

70.4667

Div Yield

0.0484

P/S

2.7126

EV Multiple

-17.7429

P/FV

1.6869

Div Yield %

4.8352

P/E

8.1682

PEG

0.7714

Payout

0.4023

Current Ratio

21.7127

Quick Ratio

21.7127

Cash Ratio

17.3453

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

0.6271

Pretax Margin

0.3296

Net Margin

0.3275

Eff Tax Rate

0.0064

ROA

0.0148

ROE

0.2105

ROCE

0.0287

NI/EBT

0.9938

EBT/EBIT

0.5255

EBIT/Rev

0.6271

Debt Ratio

0.0071

D/E

0.0991

LT Debt/Cap

0.0902

Total Debt/Cap

0.0902

Int Coverage

3.7801

CF/Debt

2.6526

Equity Multi

13.9530

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

4.1995

Asset Turnover

0.0452

OCF/Share

5.6721

FCF/Share

4.6774

Cash/Share

63.4799

OCF/Sales

0.4169

FCF/OCF

0.8246

CF Coverage

2.6526

ST Coverage

0.0000

CapEx Coverage

5.7024

Div&CapEx Cov

2.0350

P/BV

1.6869

P/B

1.6869

P/S

2.7126

P/E

8.1682

P/FCF

7.8906

P/OCF

6.4174

P/CF

6.4174

PEG

0.7714

P/S

2.7126

EV Multiple

-17.7429

P/FV

1.6869

DPS

1.7600

Latest Headlines (EST)

Benzinga Jan 18, 07:31 Nasdaq Futures Surge As TSMC Sets Positive Tone To Tech Earnings Season: Analyst Cautions New Bull Market Needs 'Heavier Lifting' The Motley Fool Dec 24, 06:45 Prediction: You Won't Regret Buying These 3 No-Brainer High-Yield Dividend Stocks The Motley Fool Dec 24, 06:45 Prediction: You Won't Regret Buying These 3 No-Brainer High-Yield Dividend Stocks The Motley Fool Dec 17, 05:03 These 8 Winning Bank Stocks Are 12% of My Portfolio. Here Is What I Think About All of Them. GlobeNewswire Inc. Dec 04, 16:30 Notable Labs to Participate in JMP Securities Hematology and Oncology Summit GlobeNewswire Inc. Nov 21, 06:03 Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China GlobeNewswire Inc. Nov 20, 16:41 Connect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023 GlobeNewswire Inc. Nov 20, 16:41 Connect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023 Zacks Investment Research Oct 24, 18:30 Bank of NT Butterfield & Son (NTB) Reports Q3 Earnings: What Key Metrics Have to Say

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.44 05/06/2024 04/23/2024 05/07/2024 05/21/2024
0.44 02/23/2024 02/12/2024 02/26/2024 03/11/2024
0.44 11/07/2023 10/24/2023 11/08/2023 11/22/2023
0.44 08/11/2023 07/31/2023 08/14/2023 08/28/2023
0.44 05/05/2023 04/24/2023 05/08/2023 05/22/2023
0.44 02/24/2023 02/13/2023 02/27/2023 03/14/2023
0.44 11/10/2022 10/31/2022 11/14/2022 11/28/2022
0.44 08/05/2022 07/25/2022 08/08/2022 08/22/2022
0.44 05/13/2022 05/02/2022 05/16/2022 05/31/2022
0.44 02/25/2022 02/14/2022 02/28/2022 03/14/2022
0.44 11/09/2021 10/27/2021 11/10/2021 11/24/2021
0.44 08/09/2021 07/26/2021 08/10/2021 08/24/2021
0.44 05/11/2021 04/28/2021 05/12/2021 05/26/2021
0.44 02/23/2021 02/10/2021 02/24/2021 03/10/2021
0.44 11/10/2020 10/28/2020 11/12/2020 11/30/2020
0.44 08/04/2020 07/22/2020 08/05/2020 08/19/2020
0.44 05/13/2020 04/30/2020 05/14/2020 05/28/2020
0.44 02/25/2020 02/13/2020 02/26/2020 03/11/2020
0.44 11/01/2019 10/22/2019 11/04/2019 11/15/2019
0.44 08/02/2019 07/23/2019 08/05/2019 08/16/2019
0.38 11/02/2018 10/23/2018 11/05/2018 11/16/2018
0.38 08/03/2018 07/24/2018 08/06/2018 08/17/2018
0.38 05/03/2018 04/24/2018 05/04/2018 05/15/2018
0.38 02/23/2018 02/15/2018 02/26/2018 03/09/2018
0.32 11/10/2017 11/01/2017 11/13/2017 11/27/2017
0.32 08/10/2017 07/26/2017 08/14/2017 08/28/2017
0.32 05/11/2017 04/27/2017 05/15/2017 05/30/2017
0.32 03/09/2017 03/10/2017 03/13/2017 03/27/2017
0.10 11/09/2016 10/26/2016 11/14/2016 11/28/2016